Skip to content

Investigating the effect of Basil (Ocimum Basilicum) capsules on severity of premenstrual syndrome symptoms

Investigating the effect of Basil (Ocimum Basilicum) capsules on severity of premenstrual syndrome symptoms in students of the Kermanshah university of medical sciences: a randomized, Triple-blind, placebo-controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160427027633N12
Enrollment
84
Registered
2025-02-16
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual syndrome. Premenstrual tension syndrome

Interventions

Intervention 1: Intervention group: 7 days before the start of menstruation until 3 days after menstrual bleeding, they will receive one capsule of 300 mg of basil orally for two cycles. Intervention

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Regular menstruation of 21-35 days Age 18-35 years Single Suffering from premenstrual syndrome Body mass index between 19.8-26 Physical and mental health Not using hormonal, coagulation, anti-depressant and herbal medicines No diet Living in the dormitory of Kermanshah University of Medical Sciences

Exclusion criteria

Exclusion criteria: Stressful events in the last 3 months Consumption of alcohol or drugs and smoking Being allergic to basil

Design outcomes

Primary

MeasureTime frame
Severity of premenstrual syndrome symptoms. Timepoint: The first assessment before the intervention and the second assessment in one month after the intervention and the third assessment in 2 months after the intervention. Method of measurement: Premenstrual symptoms screening tool.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactForuzan Sharifipour

Kermanshah University of Medical Sciences

sharifipour_fr91@yahoo.com+98 83 3835 8943

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026